Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609

Watchlist Manager
Shanghai HeartCare Medical Technology Corp Ltd Logo
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Watchlist
Price: 24 HKD 7.62% Market Closed
Market Cap: 932m HKD
Have any thoughts about
Shanghai HeartCare Medical Technology Corp Ltd?
Write Note

Gross Margin
Shanghai HeartCare Medical Technology Corp Ltd

66.2%
Current
67%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
66.2%
=
Gross Profit
166.3m
/
Revenue
251.2m

Gross Margin Across Competitors

Country CN
Market Cap 866m HKD
Gross Margin
66%
Country US
Market Cap 205.2B USD
Gross Margin
56%
Country US
Market Cap 193.1B USD
Gross Margin
67%
Country US
Market Cap 148.6B USD
Gross Margin
64%
Country US
Market Cap 132.9B USD
Gross Margin
69%
Country IE
Market Cap 109.9B USD
Gross Margin
65%
Country US
Market Cap 64.8B USD
Gross Margin
45%
Country DE
Market Cap 56.6B EUR
Gross Margin
38%
Country CN
Market Cap 326.2B CNY
Gross Margin
64%
Country US
Market Cap 42.2B USD
Gross Margin
79%
Country US
Market Cap 37.7B USD
Gross Margin
41%
No Stocks Found

Shanghai HeartCare Medical Technology Corp Ltd
Glance View

Market Cap
932m HKD
Industry
Health Care

Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-08-20. The firm's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The firm's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The firm's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The firm distributes its products within the domestic market.

Intrinsic Value
34.43 HKD
Undervaluation 30%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
66.2%
=
Gross Profit
166.3m
/
Revenue
251.2m
What is the Gross Margin of Shanghai HeartCare Medical Technology Corp Ltd?

Based on Shanghai HeartCare Medical Technology Corp Ltd's most recent financial statements, the company has Gross Margin of 66.2%.